Fingerprint
Dive into the research topics of 'ANTI-CD22 90y-epratuzumab tetraxetan combined with anti-cd20 veltuzumab: A phase I study in patients with relapsed/refractory, aggressive non-hodgkin lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically